WallStSmart
PROF

Profound Medical Corp

NASDAQ: PROF · HEALTHCARE · MEDICAL DEVICES

$7.22
-0.69% today

Updated 2026-05-06

Market cap
$248.97M
P/E ratio
P/S ratio
15.47x
EPS (TTM)
$-1.41
Dividend yield
52W range
$4 – $9
Volume
0.2M

Profound Medical Corp (PROF) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+14.7%
Last 4 quarters
Revenue YoY growth
+13.9%
Most recent quarter
EPS YoY growth
-35.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+6.6%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+7.3%
2026-03-10
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-10$-0.27+10.6%$5.23$5.61+7.3%
2025-11-13$0.26+168.4%$6.47$6.85+5.9%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.30$-0.27+10.6%$6.07M+13.9%
2025-09-30$-0.38$0.26+168.4%$5.23M+36.6%
2025-06-30$-0.27$-0.52-92.6%$2.21M-1.0%
2025-03-31$-0.28$-0.36-27.4%$2.62M+82.1%
2024-12-31$-0.32$-0.20+38.0%$5.33M+100.1%
2024-09-30$-0.30$-0.38-26.7%$3.83M+121.6%
2024-06-30$-0.29$-0.28+3.4%$2.23M+39.4%
2024-03-31$-0.30$-0.26+13.3%$1.44M-22.6%
2023-12-31$-0.32$-0.42-31.2%$2.66M
2023-09-30$-0.33$-0.26+21.2%$1.73M
2023-06-30$-0.34$-0.35-2.9%$1.60M
2023-03-31$-0.34$-0.32+5.9%$1.86M

Frequently asked questions

Has Profound Medical Corp beaten earnings estimates?
Profound Medical Corp has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +14.7% over the last 4 quarters.
How does PROF stock react to earnings?
PROF stock has moved an average of +6.6% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.
What is Profound Medical Corp's revenue growth rate?
Profound Medical Corp reported year-over-year revenue growth of +13.9% in its most recent quarter, with EPS growing -35.0% year-over-year.